MIST
Milestone Pharmaceuticals Inc
0.8097$
-0.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2,116.7% | -94.7% | -7.1% | -3.8% | +4.0% | +3.8% | +3.7% | -10.7% | +36.0% | +64.7% | +1.8% | – | |
| – | -34.6% | -19.4% | -8.0% | +0.6% | +5.4% | -8.3% | -3.2% | -4.4% | +184.2% | -63.9% | +144.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -179.8% | – | -81.6% | +1,447.6% | +42.2% | -141.2% | – | – | +15,895.6% | -105.2% | – | |
| – | +64.7% | +4.6% | -77.4% | -42.9% | +450.0% | -72.7% | +83.3% | -82.0% | +455.0% | +309.1% | -43.0% | – | |
| – | – | – | – | -31.6% | +198.3% | +73.7% | -70.4% | -458.5% | – | -3,060.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.7% | +3,231,800.0% | -100.9% | – | -67.6% | +483.3% | -74.3% | +137,849.5% | -26.6% | +159.0% | -90.8% | – | |
| – | – | -193.5% | – | -114.8% | – | +58.0% | -113.1% | – | +529.7% | -106.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.